(thirdQuint)Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors.

 OBJECTIVES: - To determine the safety and efficacy of antiepileptic drug monotherapy comprising levetiracetam or pregabalin in treating seizures in patients undergoing chemotherapy and/or radiotherapy for primary brain tumors.

 OUTLINE: This is a multicenter study.

 Patients are randomized to 1 of 2 treatment arms.

 - Arm I: Patients receive levetiracetam.

 - Arm II: Patients receive pregabalin.

 Patients are followed at 2 weeks, 2 months, 6 months, and then at 1 year.

.

 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors@highlight

RATIONALE: Levetiracetam and pregabalin are drugs that treat seizures.

 It is not yet known which drug is more effective in treating seizures caused by primary brain tumors.

 PURPOSE: This randomized phase II trial is studying the side effects and how well levetiracetam or pregabalin work in treating seizures in patients undergoing chemotherapy and/or radiation therapy for primary brain tumors.

